Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (131-140 of 740) with videos related to

Pageof 74
Sort By:
Cancer|March 20, 2002
A prospective study of pulmonary function in patients treated with paclitaxel and carboplatinIoanna Dimopoulou, Heleni Galani, Urania Dafni, et al.
Haematologica|December 11, 2008
Treatment of light chain deposition disease with bortezomib and dexamethasoneEfstathios Kastritis, Magdalini Migkou, Maria Gavriatopoulou, et al.
Journal of Blood Medicine|November 8, 2019
Evaluating ibrutinib in the treatment of symptomatic Waldenstrom's macroglobulinemiaAristea-Maria Papanota, Ioannis Ntanasis-Stathopoulos, Efstathios Kastritis, et al.
Endocrine|April 24, 2013
Metachronous appearance of second malignancies in medullary thyroid carcinoma (MTC) patients: a diagnostic challenge and brief review of the literatureMaria Alevizaki, Elena Kyratzoglou, Aristoteles Bamias, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 6, 2010
Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapyGeorge Bozas, Evangelos Terpos, Dimitra Gika, et al.
Seminars in Oncology|April 30, 2003
2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemiaDonna M Weber, Meletios A Dimopoulos, Kay Delasalle, et al.
American Journal of Hematology|October 23, 2021
Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologistEleni Korompoki, Maria Gavriatopoulou, Despina Fotiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Relapse of ovarian cancer with bone marrow infiltration and concurrent emergence of therapy-related acute myeloid leukemia: a case reportDimitrios Christoulas, Charis Matsouka, Ioannis Chatzinikolaou, et al.
Clinical Lymphoma & Myeloma|April 28, 2006
Non-Hodgkin's lymphoma of the renal pelvisGeorge Bozas, Anna Tassidou, Lia A Moulopoulos, et al.
International Journal of Molecular Sciences|July 13, 2024
The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple MyelomaPanagiotis Malamos, Christina Papanikolaou, Maria Gavriatopoulou, et al.
Pageof 74

Showing results (131-140 of 740) with videos related to

Sort By:
Pageof 74
Cancer|March 20, 2002
A prospective study of pulmonary function in patients treated with paclitaxel and carboplatinIoanna Dimopoulou, Heleni Galani, Urania Dafni, et al.
Haematologica|December 11, 2008
Treatment of light chain deposition disease with bortezomib and dexamethasoneEfstathios Kastritis, Magdalini Migkou, Maria Gavriatopoulou, et al.
Journal of Blood Medicine|November 8, 2019
Evaluating ibrutinib in the treatment of symptomatic Waldenstrom's macroglobulinemiaAristea-Maria Papanota, Ioannis Ntanasis-Stathopoulos, Efstathios Kastritis, et al.
Endocrine|April 24, 2013
Metachronous appearance of second malignancies in medullary thyroid carcinoma (MTC) patients: a diagnostic challenge and brief review of the literatureMaria Alevizaki, Elena Kyratzoglou, Aristoteles Bamias, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 6, 2010
Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapyGeorge Bozas, Evangelos Terpos, Dimitra Gika, et al.
Seminars in Oncology|April 30, 2003
2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemiaDonna M Weber, Meletios A Dimopoulos, Kay Delasalle, et al.
American Journal of Hematology|October 23, 2021
Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologistEleni Korompoki, Maria Gavriatopoulou, Despina Fotiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Relapse of ovarian cancer with bone marrow infiltration and concurrent emergence of therapy-related acute myeloid leukemia: a case reportDimitrios Christoulas, Charis Matsouka, Ioannis Chatzinikolaou, et al.
Clinical Lymphoma & Myeloma|April 28, 2006
Non-Hodgkin's lymphoma of the renal pelvisGeorge Bozas, Anna Tassidou, Lia A Moulopoulos, et al.
International Journal of Molecular Sciences|July 13, 2024
The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple MyelomaPanagiotis Malamos, Christina Papanikolaou, Maria Gavriatopoulou, et al.
Pageof 74